Funding opportunity for NHS Scotland Health Boards to trial Cancer Innovation Challenge PROMs PREMs innovations
FUNDING CALL BRIEF
NHS Scotland Territorial Health Boards can apply for a grant of up to £30,000 (inc VAT) to cover costs involved in trialling one or both of the Cancer Innovation Challenge’s Phase 2 PROMs PREMs innovations (from My Clinical Outcomes and Px HealthCare) for a period of up to 6 months ending 31 December 2019. We anticipate each applicant Health Board to include an element of in kind contribution to the proposed trial.
Summary
The Data Lab, funded by the Scottish Government through the Scottish Funding Council, and in collaboration with DHI Scotland and Stratified Medicine Scotland, will award grants of up to £30,000 (inc VAT) to NHS Scotland Territorial Health Boards to cover costs involved in taking on one or both of the Cancer Innovation Challenge’s Phase 2 PROMs PREMs innovations for a 6 month trial.
These innovations are the final two projects funded in the “New approaches to record and integrate cancer PROMS and PREMs” and have been developed and evaluated in pilot NHS Scotland Territorial Health Boards (NHS Lothian and NHS Ayrshire & Arran).
What the funding can and cannot cover
The funding can cover any costs directly incurred by the implementation of one or both of the Cancer Innovation Challenge solutions for a trial period. The trial MUST be in cancer care. This can include the following costs:
- Staffing resource:
- in relation to change management
- in relation to design work with the company
- eHealth/IT staffing to implement solution
- in relation to training
- Systems integration:
- In relation to integrating the solutions into existing systems such as TrakCare, Clinical Portal
- Patient engagement/feedback
- Patient engagement opportunities
- Activities to measure patient impact
- Time from the company:
- In relation to any design work required to customise to the NHS Scotland Territorial Health Board’s needs
The funding cannot cover:
- Wider implementation of the solution in the pilot NHS Scotland Territorial Health Board (i.e. NHS Ayrshire & Arran cannot apply for funding for implementing My Clinical Outcomes and NHS Lothian cannot apply for funding for implementing Px HealthCare’s OWise for Scotland)
- Any costs related to implementation of any solution outwith those funded by the Cancer Innovation Challenge
- Licence fees to the companies (the companies are aware of this limitation)
Who is eligible for this funding?
This funding is only available to NHS Scotland Territorial Health Boards. The Board must evidence engagement with the chosen company solution as part of their submission. We anticipate each applicant Health Board to include an element of in kind contribution to the proposed trial.
NHS Ayrshire & Arran may not apply for wider implementation of My Clinical Outcomes in their Board.
NHS Lothian may not apply for wider implementation of Px HealthCare’s OWise in their Board.
Health Boards may submit joint applications with NHS Ayrshire & Arran or NHS Lothian (to gain from previous learnings). The conditions for a joint application are:
- The patients must be in the non - Ayrshire & Arran and Lothian Health Board area
- The lead application must be the non- Ayrshire & Arran and Lothian Health Board
The Data Lab, funded by the Scottish Funding Council, and in collaboration with DHI Scotland and Stratified Medicine Scotland, reserve the right to adjust the funding available. The total funding available may be subject to change.
What are the two solutions?
My Clinical Outcomes
My Clinical Outcomes (MCO) is an established clinical technology platform that automates the collection and analysis of Patient Reported Outcome Measures (PROMs) in routine clinical practice.
MCO Key features:
- Configurable and cost-effective web-platform for remotely collecting and using PROMs within weeks.
- Work with clinicians to configure the platform to local requirements - patient cohorts, assessment details, schedule and frequency flexible and set locally.
- Initial focus may be on measuring symptoms and toxicity during acute treatment, tracking quality of life during follow-up or screening for late-effects.
- Following the Cancer Innovation Challenge, MCO is in routine use by the chemotherapy service at NHS Ayrshire and Arran with initial breast cancer pathway design at The Beatson West of Scotland Cancer Centre complete (go-live pending funding).
- Elsewhere in the UK, MCO is in use at over 70 hospitals in a variety of conditions and care settings, notably working with Macmillan Cancer Support and The Royal College of Radiologists at an initial three NHS cancer centres to enhance the long-term follow-up of radiotherapy patients (see project video and feedback here).
Further information about My Clinical Outcomes can be found at the bottom of the page in the expandable section
OWise for Scotland (from Px HealthCare)
Px HealthCare (Px) has developed OWise, the UK’s leading, patient-centric mobile app platform improving patient experience, hospital efficiency and oncology outcomes in real-time.
Fully in line with the Scottish government strategy “Beating Cancer: Ambition and Action” (2016) and the country’s focus on practising Realistic Medicine, OWise has already been shown to improve the patient–physician relationship (Young-Afat et al. 2016, JMIR Cancer 2016;2(1):e8). Currently available for breast cancer patients, it will become available for other tumour sites later in 2019.
OWise is a mobile app and website, which:
- Enables people living with breast cancer to better informed and have access to a range of personalised self-management and support tools
- Empowers patients to track, review and share their daily, remotely-monitored PRO-data with clinicians who can directly access this from within TrakCare©
- Is aligned with UKONS to give patients real-time, smart alerts nudging them to seek appropriate medical support when their side effects exacerbate.
View short video about OWise
Further information about Px HealthCare and OWise can be found at the bottom of the page in the expandable section
Dates and Deadlines
The call opens at 12 NOON on Monday 1 April 2019.
APPLICATION DEADLINE - The call will close at noon on Wednesday 1 May 2019. You must submit your full application by 12 noon (BST) on 1 May 2019. Late applications will not be accepted.
Further Information
Please expand the sections below for further information.
If you have any further questions, please contact Steph Wright, CIC Programme Manager on steph.wright [at] thedatalab.com (subject: NHS%20Scotland%20Health%20Board%20Funding%20Opportunity%20Enquiry)
